A Post Marketing Surveillance Study To Determine The Safety, Tolerability And Effectiveness Of Doxazosin Mesylate GITS Among Filipino Adult Males With Benign Prostatic Hyperplasia (BPH).

Trial Profile

A Post Marketing Surveillance Study To Determine The Safety, Tolerability And Effectiveness Of Doxazosin Mesylate GITS Among Filipino Adult Males With Benign Prostatic Hyperplasia (BPH).

Completed
Phase of Trial: Phase IV

Latest Information Update: 19 Sep 2011

At a glance

  • Drugs Doxazosin (Primary)
  • Indications Benign prostatic hyperplasia
  • Focus Adverse reactions
  • Sponsors Pfizer
  • Most Recent Events

    • 09 Feb 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 09 Feb 2011 Actual end date (Jan 2011) added as reported by ClinicalTrials.gov.
    • 02 Aug 2010 Planned end date changed from 1 Dec 2010 to 1 Sep 2011 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top